Skip to main content
OpenTrials

Clinical trial condition

Anemia

Explore clinical trials studying Anemia. Study availability and eligibility vary by location and protocol.

2,225 public trials 353 recruiting studies
Refine in advanced search Browse all conditions

Anemia trial results

Completed

A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises

NCT04935879

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations
  • University of South Alabama Children's and Women's Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • University of South Alabama Strada Patient Care Center Mobile, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 58 locations
View Trial Details
Completed

Ferric Carboxymaltose Methemoglobinemia Study

NCT06958822

Conditions
Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +9 more
Locations
  • University of Health Sciences Adana City Health Application and Research Center Adana, Turkey (Türkiye)
  • Akdeniz University Hospital Konyaalti, Antalya, Turkey (Türkiye)
  • Balıkesir University Health Practice and Research Hospital Merkez, Balıkesir, Turkey (Türkiye)
  • Bursa City Hospital Nilufer, Bursa, Turkey (Türkiye)
View all 23 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)

NCT05096403

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Lakes Research Miami Lakes, Florida, United States
  • University of Iowa Hospitals & Clinics - The Hemophilia Treatment Center (HTC) Iowa City, Iowa, United States
  • Weill Cornell Medicine / NewYork Presbyterian Hospital New York, United States
View all 44 locations
View Trial Details
Completed

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

NCT03474965

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +19 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • Childrens National Hospital Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
  • Joe DiMaggio Childrens Hospital Hollywood, Florida, United States
View all 35 locations
View Trial Details

Related conditions